Mamdani, BashirMamdani, Meenal2019-09-252019-09-252011-03-092005-100975-5691http://hdl.handle.net/20.500.12424/176785"It has become increasingly difficult and expensive to test drugs in western countries, with their strict regulations, elabo-rate safety requirements, and small populations, all of which make the recruitment of research subjects difficult. Consequently, many organisations are now outsourcing some of their trials to developing countries such as China, Indonesia, Thailand, and India. Under pressure from pharmaceutical multinationals, among others, the government of India removed the phase-lag rule and now allows foreign pharmaceutical com-panies to conduct drug trials in India simultaneously with same-phase trials in other countries. The old rule was designed to protect Indians from being used as guinea pigs in the testing of unproved drugs of foreign origin; trials of domestically discovered drugs were not subject to this provisionengWith permission of the license/copyright holdercolonizationmedical ethicsBioethicsSocial ethicsSexual orientation/genderMedical ethicsHealth ethicsArticle